4//SEC Filing
WIGGANS THOMAS G 4
Accession 0001213900-23-088896
CIK 0001788028other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:14 PM ET
Size
8.5 KB
Accession
0001213900-23-088896
Insider Transaction Report
Form 4
WIGGANS THOMAS G
Director
Transactions
- Purchase
Voting Common Stock
2023-11-20$0.63/sh+10,000$6,309→ 30,000 total - Purchase
Voting Common Stock
2023-11-16$0.60/sh+10,000$5,965→ 10,000 total - Purchase
Voting Common Stock
2023-11-17$0.60/sh+10,000$5,966→ 20,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001208907
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:14 PM ET
- Size
- 8.5 KB